Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies S Frantz, MJ Hundertmark, J Schulz-Menger, FM Bengel, J Bauersachs European heart journal 43 (27), 2549-2561, 2022 | 226 | 2022 |
Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction MK Burrage, M Hundertmark, L Valkovič, WD Watson, J Rayner, ... Circulation 144 (21), 1664-1678, 2021 | 66 | 2021 |
Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: the randomized, controlled EMPA-VISION trial MJ Hundertmark, A Adler, C Antoniades, R Coleman, JL Griffin, ... Circulation 147 (22), 1654-1669, 2023 | 34 | 2023 |
Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction MA Peterzan, WT Clarke, CA Lygate, HA Lake, JYC Lau, JJ Miller, ... Circulation 141 (24), 1971-1985, 2020 | 27 | 2020 |
Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure MJ Hundertmark, OF Agbaje, R Coleman, JT George, R Grempler, ... ESC Heart Failure 8 (4), 2580-2590, 2021 | 25 | 2021 |
Localized rest and stress human cardiac creatine kinase reaction kinetics at 3 T WT Clarke, MA Peterzan, JJ Rayner, RA Sayeed, M Petrou, ... NMR in Biomedicine 32 (6), e4085, 2019 | 21 | 2019 |
Quantifying the effect of dobutamine stress on myocardial Pi and pH in healthy volunteers: A 31P MRS study at 7T A Apps, L Valkovič, M Peterzan, JYC Lau, M Hundertmark, W Clarke, ... Magnetic Resonance in Medicine 85 (3), 1147-1159, 2021 | 17 | 2021 |
Eya4 Induces Hypertrophy via Regulation of p27kip1 T Williams, M Hundertmark, P Nordbeck, S Voll, PA Arias-Loza, D Oppelt, ... Circulation: Cardiovascular Genetics 8 (6), 752-764, 2015 | 14 | 2015 |
Capnocytophaga canimorsus as Cause of Fatal Sepsis M Hundertmark, T Williams, A Vogel, M Moritz, P Bramlage, N Pagonas, ... Case reports in infectious diseases 2019 (1), 3537507, 2019 | 11 | 2019 |
Association between sarcomeric variants in hypertrophic cardiomyopathy and myocardial oxygenation: insights from a novel oxygen-sensitive cardiovascular magnetic resonance approach B Raman, EM Tunnicliffe, K Chan, R Ariga, M Hundertmark, EO Ohuma, ... Circulation 144 (20), 1656-1658, 2021 | 10 | 2021 |
A phase 2a trial investigating ninerafaxstat–a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE) M Hundertmark, AG Siu, V Matthews, AJ Lewis, JT Grist, J Patel, ... European Heart Journal 43 (Supplement_2), ehac544. 246, 2022 | 6 | 2022 |
Diagnosing post-capillary hypertension in patients with left heart disease: impact of new guidelines G Güder, T Reiter, G Fette, M Hundertmark, S Frantz, C Morbach, S Störk, ... Clinical Research in Cardiology, 1-10, 2023 | 4 | 2023 |
Should CMR be the default imaging modality in clinical trials for heart failure? M Hundertmark Cardiovascular diagnosis and therapy 10 (3), 554, 2020 | 4 | 2020 |
143 measuring pcr/atp as a marker of myocardial energetics across the spectrum of metabolic cardiac disease JA Henry, E Levelt, J Rayner, M Hundertmark, M Peterzan, P Green, ... Heart 108 (Suppl 1), A109-A110, 2022 | 3 | 2022 |
intentional weight loss as a novel treatment for heart failure with preserved ejection fraction MJ Hundertmark, M Burrage, J Miller, W Watson, M Peterzan, J Rayner, ... Circulation 144 (Suppl_1), A11064-A11064, 2021 | 2 | 2021 |
Diabetes mellitus and heart failure: insights from a toxic relationship M Hundertmark, E Wicks Practical Diabetes 35 (4), 112-116b, 2018 | 2 | 2018 |
Comparison of human cardiac 31P-MRS on 3TTrio and Prisma scanners J Ellis, M Hundertmark, M Spartera, W Watson, CT Rodgers, L Valkovic Proc. ISMRM, 2019 | 1 | 2019 |
Ninerafaxstat Modulates Cardiac Energy Metabolism in Cardio-metabolic Syndromes: A Mechanistic, Hyperpolarized MR Trial M Hundertmark, O Rider, J Patel, D Tyler, P Chamberlin, J Miller, ... Journal of Cardiovascular Magnetic Resonance 26, 2024 | | 2024 |
Compartment-based reconstruction of acquisition-weighted 31P cardiac MRSI reduces sensitivity to cardiac motion and scan planning A Tyler, MJ Hundertmark, JJ Miller, O Rider, DJ Tyler, L Valkovič Frontiers in Physiology 14, 1325458, 2024 | | 2024 |
Modulating Cardiac Energetics in Cardio-Metabolic Syndromes: A mechanistic, hyperpolarized MR Trial of Ninerafaxstat Treatment MJ Hundertmark, AG Siu, V Matthews, AJM Lewis, JT Grist, J Patel, ... bioRxiv, 2024.04. 24.591019, 2024 | | 2024 |